Ferric maltol | m-entrepreneurship.com

Product Name :
Ferric maltol

Search keywords :
AB10

drugId :
null

Target Vo:
Unidentified

Target Vo Short Name :
Unidentified

Moa_Name:
Iron replacements

First Approval Country :
EU

First Approval Date Filter:
2016

Origin Company_Name :
Shield Therapeutics

Active Company_Name :
Jiangsu Aosaikang Pharmaceutical Co Ltd

Active Indication_Name:
Iron deficiency

In Active Indication_Name:
Hypertension, Pulmonary

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Phase 1 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
RIP Antibody
MUC16 Antibody (YA890)
Calnexin Antibody: Calnexin Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 68 kDa, targeting to Calnexin. It can be used for WB,IHC-F,IHC-P,ICC/IF,ELISA assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts